Updated
Updated · Fox News · Sep 14
Becky Drexler's 18-Week Ovarian Cancer Treatment Clears PET Scan Spots at Midpoint
Updated
Updated · Fox News · Sep 14

Becky Drexler's 18-Week Ovarian Cancer Treatment Clears PET Scan Spots at Midpoint

1 articles · Updated · Fox News · Sep 14

Summary

  • Late-July PET results showed Becky Drexler’s current ovarian cancer treatment is working, with previously seen spots no longer visible and no new ones detected.
  • The 65-year-old Minnesota woman began the 18-week regimen in May 2026 after winter gastric symptoms led to a PET scan that found a recurrent tumor around her small intestine, followed by surgery.
  • Post-surgery imaging still showed a couple of spots, prompting treatment with carboplatin, taxol and Avastin; the cycle is expected to finish at the end of September.
  • Depending on her next PET scan, Drexler said she will likely move to an antibody-drug conjugate maintenance therapy, a recently approved targeted option.
  • Her case underscores a broader ovarian cancer challenge: about 75% of patients are diagnosed at stage 3 or 4 because symptoms such as bloating, constipation and abdominal pain are often vague.

Insights

Will new 2026 breakthroughs in overcoming treatment resistance finally turn recurrent ovarian cancer into a functionally curable disease?
Could the secret to stopping aggressive ovarian cancer lie in targeting the fallopian tubes before vague symptoms ever appear?
Why do we still lack reliable screening for a deadly cancer that perfectly mimics ordinary signs of aging until it is too late?